AFYX Therapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • M&A

AFYX Therapeutics General Information

Description

Operator of a drug delivery company intended to develop a pipeline of targeted treatments for conditions that currently lack approved therapy options. The company's product is flexible, biodegradable, and adhesive to mucosal surfaces, and is designed with electrospinning technology, that delivers a therapeutic directly to the site in need, without interfering with the patient's daily activities, enabling patients to get relief and facilitating the recovery time required for mucosal lesions.

Contact Information

Website
www.afyxtx.com
Formerly Known As
Dermtreat
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Ole Maaløes Vej 3
  • 2200 Copenhagen
  • Denmark
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Therapeutic Devices
Acquirer
Inphena
Vertical(s)
Corporate Office
  • Ole Maaløes Vej 3
  • 2200 Copenhagen
  • Denmark

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AFYX Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 09-Jan-2024 Completed Generating Revenue
5. Later Stage VC 24-Jun-2019 Completed Clinical Trials - Phase 2
4. Grant 01-Jan-2019 Completed Startup
3. Early Stage VC (Series A) 08-May-2017 Completed Startup
2. Grant $1.95M Completed Startup
1. Early Stage VC 31-Dec-2015 $1.95M $1.95M Completed Startup
To view AFYX Therapeutics’s complete valuation and funding history, request access »

AFYX Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class A
Class A
To view AFYX Therapeutics’s complete cap table history, request access »

AFYX Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a drug delivery company intended to develop a pipeline of targeted treatments for conditions that currently
Drug Delivery
Copenhagen, Denmark
7 As of 2023

Vienna, Austria
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

AFYX Therapeutics Competitors (1)

One of AFYX Therapeutics’s competitors is Apeptico, a Formerly VC-backed company based in Vienna, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Apeptico Formerly VC-backed Vienna, Austria
You’re viewing 1 of 1 competitors. Get the full list »

AFYX Therapeutics Patents

AFYX Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260272942-A1 Combining nimorazole, chemotherapy and radiotherapy Pending 14-Mar-2025
EP-4827873-A1 Combining nimorazole, chemotherapy and radiotherapy for use in treating or preventing cancer Pending 14-Mar-2025
WO-2026189632-A1 Combining nimorazole, chemotherapy and radiotherapy for use in treating or preventing cancer Pending 14-Mar-2025
WO-2026189634-A1 Combining nimorazole, chemotherapy and radiotherapy for use in treating or preventing cancer Pending 14-Mar-2025
WO-2023094457-A1 Mucosal patches and methods of use thereof Inactive 23-Nov-2021 A61K9/0034
To view AFYX Therapeutics’s complete patent history, request access »

AFYX Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AFYX Therapeutics Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
EASME - EU Executive Agency for SMEs Corporation
Innovationsfonden Accelerator/Incubator Minority
Lundbeckfonden Limited Partner Minority
Lundbeckfonden BioCapital Venture Capital Minority
Novo Holdings Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

AFYX Therapeutics FAQs

  • When was AFYX Therapeutics founded?

    AFYX Therapeutics was founded in 2013.

  • Where is AFYX Therapeutics headquartered?

    AFYX Therapeutics is headquartered in Copenhagen, Denmark.

  • What is the size of AFYX Therapeutics?

    AFYX Therapeutics has 7 total employees.

  • What industry is AFYX Therapeutics in?

    AFYX Therapeutics’s primary industry is Drug Delivery.

  • Is AFYX Therapeutics a private or public company?

    AFYX Therapeutics is a Private company.

  • What is AFYX Therapeutics’s current revenue?

    The current revenue for AFYX Therapeutics is .

  • How much funding has AFYX Therapeutics raised over time?

    AFYX Therapeutics has raised $32.4M.

  • Who are AFYX Therapeutics’s investors?

    EASME - EU Executive Agency for SMEs, Innovationsfonden, Lundbeckfonden, Lundbeckfonden BioCapital, and Novo Holdings are 5 of 8 investors who have invested in AFYX Therapeutics.

  • Who are AFYX Therapeutics’s competitors?

    Apeptico is a competitor of AFYX Therapeutics.

  • When was AFYX Therapeutics acquired?

    AFYX Therapeutics was acquired on 09-Jan-2024.

  • Who acquired AFYX Therapeutics?

    AFYX Therapeutics was acquired by Inphena.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process